Analyst opinions: changes for Société Générale, TotalEnergies, Engie...
Target price increases dominate the session, from Wolters Kluwer to Air France-KLM, while Nexity, Gecina and several services stocks see their target cut. Gaps between target and share price range from a few points on Euronext to more than 300% on Adocia.
Above their target: 9 stocks · SBF 120 stocks covered: 120
Stocks trading above their target: Eurofins Scientific (-15.5%) · Air France-KLM (-10.1%) · Icade (-9.7%) · Teleperformance (-9.3%) · Rémy Cointreau (-5.8%) · bioMérieux (-5.7%) · Dassault Systèmes (-5.2%) · Métropole Télévision (-1.8%) · Imerys (-0.4%)
Air France-KLM: Barclays doubles its target from 9 to 18 euros and upgrades its rating from “sell” to “buy”. Morgan Stanley (“overweight”) raises it from 13.20 to 14.90 euros, JP Morgan (“overweight”) from 14.50 to 15.50 euros. An analyst had lowered its target on November 5. Median at 12 euros, target/price gap: -10.1%.
From 90 to 115 euros at Wolters Kluwer: ING remains at “buy” and raises its target. An analyst had also raised its target on November 2. The median stands at 99 euros, target/price gap: +11%.
JCDecaux attracts two upgrades: Barclays, at “overweight”, sets its target at 31.50 euros (up from 27 euros), while Exane BNP Paribas, at “outperform”, puts it at 29.50 euros (up from 26 euros). 4 analysts had raised their targets over the last 10 days, the latest on November 5. Median at 29 euros, target/price gap: +9.3%.
Three stocks, one broker: Morgan Stanley moves on the energy and real estate sectors.
On TotalEnergies, the rating is “market weight” and the target rises from 78 to 82 euros. An analyst had raised its target on November 4. Median at 90 euros, target/price gap: +13.8%.
Conversely, Gecina's target is cut from 78 to 75 euros, with an “underweight” rating. An analyst had lowered its target on November 3. The median, at 75 euros, shows a target/price gap of +14.5%.
At Engie, the rating is “overweight” with an adjusted target from 29 to 28 euros. Median at 30 euros, target/price gap: +24.3%.
Société Générale: Barclays adjusts its target from 81 to 82 euros. An analyst had raised its target on October 30. Median at 88 euros, target/price gap: +35%.
Two brokers, two directions on Publicis Groupe: UBS downgrades its recommendation from “buy” to “hold” and cuts its target from 109 to 100 euros, while JP Morgan, at “overweight”, raises it from 133 to 145 euros. Median at 118 euros, target/price gap: +15.2%.
At Euronext, CIC Market Solutions moves from “buy” to “hold” while raising its target from 167 to 185 euros. An analyst had raised its target on November 3. Median at 177 euros, target/price gap: +2.8%.
At NRJ Group, CIC Market Solutions remains at “buy” and cuts its target from 10 to 8 euros. Portzamparc, at “buy”, sets it at 8.90 euros (versus 9.40 euros). Median at 8.45 euros, target/price gap: +42.3%.
UCB: two upgrades from brokers who remain at “buy”. Berenberg moves from 305 to 320 euros, ING from 304 to 325 euros. The median comes out at 287.50 euros, target/price gap: +1.8%.
Barclays, rating SES at “underweight”, raises its target from 3.70 to 4.20 euros. Median at 7 euros, target/price gap: +55.4%.
From 11.50 to 11 euros at Métropole Télévision: the move comes from Barclays. An analyst had lowered its target on November 4. Median at 11 euros, target/price gap: -1.8%.
Proximus: BNP Paribas Wealth Management remains at “hold” and raises its target from 6.30 to 6.60 euros. Median at 6.55 euros, target/price gap: +3.9%.
Severe cut at Nexity: still at “hold”, BNP Paribas Wealth Management cuts its target from 7.10 to 4.10 euros. An analyst had lowered its target on October 27. Median at 6.05 euros, target/price gap: +42.9%.
Target unchanged at 43 euros for Ahold Delhaize: KBC Securities remains at “buy” without changing its target. Median at 35.50 euros, target/price gap: +4.8%.
OCI jumps from 2.95 to 4.10 euros on the target at ING, which remains at “hold”. An analyst had raised its target on November 3. The median, at 4.10 euros, leaves only a target/price gap of +0.2%.
At Recticel, ING, still at “buy”, adjusts its target from 17 to 16.50 euros. Median at 14.70 euros, target/price gap: +20.1%.
Syensqo: Degroof Petercam, still at “buy”, raises its target from 84 to 90 euros. Median at 85 euros, target/price gap: +9.7%.
UBS makes multiple moves. On Beneteau, it remains at “hold” and cuts its target from 6.30 to 6 euros. An analyst had lowered its target on November 5. Median at 6 euros, target/price gap: +20%.
For Universal Music Group (UMG), UBS is at “hold” with a target of 16.60 euros. 3 analysts had raised their targets over the last 10 days, the latest on October 30. Median at 17.30 euros, target/price gap: +1.7%.
Finally, IMCD: still at “buy”, UBS raises its target from 110 to 120 euros. Median at 120.50 euros, target/price gap: +15.8%.
Selectirente: Euroland Corporate remains at “buy” and cuts its target from 110 to 107 euros. Median at 96.50 euros, target/price gap: +22.9%.
Target unchanged at 13 euros for Adocia: Invest Securities remains at “buy”. The median, at 12 euros, corresponds to a target/price gap of +329.8%.
At Theraclion, TP Icap Midcap is at “buy” with a target raised from 1.70 to 2 euros. Median at 2 euros, target/price gap: +156.4%.
Teleperformance: TP Icap Midcap (“hold”) cuts its target from 65 to 62 euros, Deutsche Bank (“hold”) from 57 to 56 euros. An analyst had raised its target on November 3. Median at 62 euros, target/price gap: -9.3%.
From 170 to 175 euros at Legrand: Deutsche Bank remains at “buy”. An analyst had raised its target on November 5. Median at 172 euros, target/price gap: +32.6%.
Sanofi: Intron Health is at “buy” with a target of 120 euros. An analyst had raised its target on November 1. Median at 88.50 euros, target/price gap: +7.2%.
Two brokers on ArcelorMittal: JP Morgan (“overweight”) adjusts its target from 70 to 69 euros, Exane BNP Paribas (“outperform”) from 71 to 70 euros. Median at 71 euros, target/price gap: +27.2%.
Portzamparc intervenes on two stocks, with a “buy” rating in both cases. Genfit sees its target rise from 22.40 to 23 euros; an analyst had raised its target on October 27. Median at 22.50 euros, target/price gap: +117.6%. Akwel, for its part, is cut from 10.90 to 10.40 euros. Median at 8.45 euros, target/price gap: +35%.
BNP Paribas: Goldman Sachs, at “buy”, sets its target at 142 euros (versus 136 euros). 3 analysts had raised their targets and 2 had lowered them over the last 10 days, the latest move dating from November 4. Median at 119 euros, target/price gap: +27.8%.
